Skip to content
PubMed This is a summary of 72 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 72 referenced papers

Top Authors

C. Prakash Gyawali
Washington University in St. Louis
John E. Pandolfino
Northwestern University
Sachin Wani
University of Colorado Anschutz Medical Campus
Rena Yadlapati
University of California San Diego
Nicholas J. Shaheen
University of North Carolina at Chapel Hill
Edoardo Savarino
University of Padua
Jesper Lagergren
Karolinska University Hospital
Prateek Sharma
University of Kansas Medical Center
Ronnie Fass
Tucson Medical Center
Prasad G. Iyer
Mayo Clinic in Arizona

Top Institutions

Ranked by publications Top 10 institutions

References

References (72)
  1. 1

    Lifestyle Intervention in Gastroesophageal Reflux Disease.

    Ness-Jensen E, Hveem K, El-Serag H, Lagergren J

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; (14(2)):175-82.e1-3.

    PMID: 25956834
  2. 2

    Long-term durability of radiofrequency ablation for Barrett's-related neoplasia.

    Haidry R, Lovat L

    Current opinion in gastroenterology 2015; (31(4)):316-20 doi:10.1097/MOG.0000000000000190.

    PMID: 26039723
  3. 3

    Pathophysiology of gastroesophageal reflux disease: new understanding in a new era.

    Herregods TV, Bredenoord AJ, Smout AJ

    Neurogastroenterology and motility 2015; (27(9)):1202-13 doi:10.1111/nmo.12611.

    PMID: 26053301
  4. 4

    The management of gastro-oesophageal reflux disease.

    Keung C, Hebbard G

    Australian prescriber 2016; (39(1)):6-10 doi:10.18773/austprescr.2016.003.

    PMID: 27041798
  5. 5

    Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment.

    Miwa H, Kondo T, Oshima T

    Current opinion in gastroenterology 2016; (32(4)):344-52 doi:10.1097/MOG.0000000000000282.

    PMID: 27206157
  6. 6

    Importance of Esophageal Manometry and pH Monitoring in the Evaluation of Patients with Refractory Gastroesophageal Reflux Disease: A Multicenter Study.

    Andolfi C, Bonavina L, Kavitt RT, et al.

    Journal of laparoendoscopic & advanced surgical techniques. Part A 2016; (26(7)):548-50 doi:10.1089/lap.2016.0189.

    PMID: 27218861
  7. 7

    Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

    Iwakiri K, Kinoshita Y, Habu Y, et al.

    Journal of gastroenterology 2016; (51(8)):751-67 doi:10.1007/s00535-016-1227-8.

    PMID: 27325300
  8. 8

    Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation: Observational cohort study with propensity score analysis.

    Asti E, Bonitta G, Lovece A, et al.

    Medicine 2016; (95(30)):e4366 doi:10.1097/MD.0000000000004366.

    PMID: 27472725
  9. 9

    Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry.

    Roman S, Holloway R, Keller J, et al.

    Neurogastroenterology and motility 2017; (29(2)) doi:10.1111/nmo.12920.

    PMID: 27477826
  10. 10

    Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign.

    Cameron GR, Desmond PV, Jayasekera CS, et al.

    Endoscopy international open 2016; (4(8)):E849-58 doi:10.1055/s-0042-109608.

    PMID: 27540572
  11. 11

    LINX® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis.

    Skubleny D, Switzer NJ, Dang J, et al.

    Surgical endoscopy 2017; (31(8)):3078-3084 doi:10.1007/s00464-016-5370-3.

    PMID: 27981382
  12. 12

    Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.

    Coyle C, Crawford G, Wilkinson J, et al.

    Alimentary pharmacology & therapeutics 2017; (45(12)):1524-1533 doi:10.1111/apt.14064.

    PMID: 28464343
  13. 13

    Assessing Old and New Diagnostic Tests for Gastroesophageal Reflux Disease.

    Vaezi MF, Sifrim D

    Gastroenterology 2018; (154(2)):289-301 doi:10.1053/j.gastro.2017.07.040.

    PMID: 28774844
  14. 14

    Management of Gastroesophageal Reflux Disease.

    Gyawali CP, Fass R

    Gastroenterology 2018; (154(2)):302-318 doi:10.1053/j.gastro.2017.07.049.

    PMID: 28827081
  15. 15

    GERD: Presence and Size of Hiatal Hernia Influence Clinical Presentation, Esophageal Function, Reflux Profile, and Degree of Mucosal Injury.

    Schlottmann F, Andolfi C, Herbella FA, et al.

    The American surgeon 2018; (84(6)):978-982.

    PMID: 29981634
  16. 16

    Gastroesophageal Reflux Disease in Obese Patients.

    Valezi AC, Herbella FAM, Schlottmann F, Patti MG

    Journal of laparoendoscopic & advanced surgical techniques. Part A 2018; (28(8)):949-952 doi:10.1089/lap.2018.0395.

    PMID: 30004267
  17. 17

    Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?

    Singh T, Sanaka MR, Thota PN

    World journal of gastrointestinal endoscopy 2018; (10(9)):165-174 doi:10.4253/wjge.v10.i9.165.

    PMID: 30283599
  18. 18

    Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications.

    Ruffner MA, Kennedy K, Cianferoni A

    Expert review of clinical immunology 2019; (15(1)):83-95 doi:10.1080/1744666X.2019.1544893.

    PMID: 30394139
  19. 19

    Endoscopic classification of reflux esophagitis.

    Hoshihara Y, Iwakiri K

    Nihon rinsho. Japanese journal of clinical medicine 2016; (74(8)):1262-1267.

    PMID: 30562426
  20. 20

    How to choose among fundoplication, magnetic sphincter augmentation or transoral incisionless fundoplication.

    Rabach L, Saad AR, Velanovich V

    Current opinion in gastroenterology 2019; (35(4)):371-378 doi:10.1097/MOG.0000000000000550.

    PMID: 31033771
  21. 21

    The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health.

    Appleton J

    Integrative medicine (Encinitas, Calif.) 2018; (17(4)):28-32.

    PMID: 31043907
  22. 22

    Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years.

    Testoni PA, Testoni S, Distefano G, et al.

    Endoscopy international open 2019; (7(5)):E647-E654 doi:10.1055/a-0820-2297.

    PMID: 31058207
  23. 23

    Functional heartburn: An underrecognized cause of PPI-refractory symptoms.

    Gabbard S, Vijayvargiya S

    Cleveland Clinic journal of medicine 2019; (86(12)):799-806 doi:10.3949/ccjm.86a.19006.

    PMID: 31821137
  24. 24

    Esophagogastric Junction Morphology on Hill's Classification Predicts Gastroesophageal Reflux with Good Accuracy and Consistency.

    Osman A, Albashir MM, Nandipati K, et al.

    Digestive diseases and sciences 2021; (66(1)):151-159 doi:10.1007/s10620-020-06146-0.

    PMID: 32078088
  25. 25

    [The role of the traditional surgical procedures for gastroesophageal reflux disease cannot be ignored].

    Zhou JH, Tan QY

    Zhonghua wai ke za zhi [Chinese journal of surgery] 2020; (58(9)):672-676 doi:10.3760/cma.j.cn112139-20200224-00125.

    PMID: 32878412
  26. 26

    Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.

    Kamboj AK, Katzka DA, Iyer PG

    Gastrointestinal endoscopy clinics of North America 2021; (31(1)):27-41 doi:10.1016/j.giec.2020.08.002.

    PMID: 33213798
  27. 27

    Gastroesophageal Reflux Disease: A Review.

    Maret-Ouda J, Markar SR, Lagergren J

    JAMA 2020; (324(24)):2536-2547 doi:10.1001/jama.2020.21360.

    PMID: 33351048
  28. 28

    The bitter tastant denatonium benzoate has no influence on the number of transient lower esophageal sphincter relaxations in health.

    Geysen H, Geeraerts A, Verbeure W, et al.

    Neurogastroenterology and motility 2021; (33(7)):e14061 doi:10.1111/nmo.14061.

    PMID: 33615641
  29. 29

    Understanding the most commonly billed diagnoses in primary care: Gastroesophageal reflux disease.

    Rogers J, Eastland T

    The Nurse practitioner 2021; (46(4)):50-55 doi:10.1097/01.NPR.0000737196.69218.b6.

    PMID: 33739328
  30. 30

    The microbiota-gut-brain axis: Focus on the fundamental communication pathways.

    Bistoletti M, Bosi A, Banfi D, et al.

    Progress in molecular biology and translational science 2020; (176()):43-110 doi:10.1016/bs.pmbts.2020.08.012.

    PMID: 33814115
  31. 31

    Clinical usefulness of esophageal high resolution manometry and adjunctive tests: An update.

    Gyawali CP, Penagini R

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2021; (53(11)):1373-1380 doi:10.1016/j.dld.2021.04.007.

    PMID: 33994122
  32. 32

    Clinical characteristics and risk factors of gastroesophageal reflux disease in Vietnamese patients with upper gastrointestinal symptoms undergoing esophagogastroduodenoscopy.

    Quach DT, Pham QTT, Tran TLT, et al.

    JGH open : an open access journal of gastroenterology and hepatology 2021; (5(5)):580-584 doi:10.1002/jgh3.12536.

    PMID: 34013058
  33. 33

    Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.

    Fabian T, Leung A

    The Surgical clinics of North America 2021; (101(3)):381-389 doi:10.1016/j.suc.2021.03.001.

    PMID: 34048759
  34. 34

    Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease.

    Losa M, Manz SM, Schindler V, et al.

    Neurogastroenterology and motility 2021; (33(9)):e14177 doi:10.1111/nmo.14177.

    PMID: 34128293
  35. 35

    Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.

    Klaver E, Bureo Gonzalez A, Mostafavi N, et al.

    United European gastroenterology journal 2021; (9(8)):929-937 doi:10.1002/ueg2.12114.

    PMID: 34228885
  36. 36

    The evolution of endoscopic therapy for Barrett's esophagus.

    Condon A, Muthusamy VR

    Therapeutic advances in gastrointestinal endoscopy 2021; (14()):26317745211051834 doi:10.1177/26317745211051834.

    PMID: 34708204
  37. 37

    Pathophysiology of gastroesophageal reflux disease-which factors are important?

    Fuchs KH, Lee AM, Breithaupt W, et al.

    Translational gastroenterology and hepatology 2021; (6()):53 doi:10.21037/tgh.2020.02.12.

    PMID: 34805575
  38. 38

    Evolution of gastroesophageal reflux disease symptoms after bariatric surgery: A dose-response meta-analysis.

    Elzouki AN, Waheed MA, Suwileh S, et al.

    Surgery open science 2022; (7()):46-51 doi:10.1016/j.sopen.2021.11.006.

    PMID: 35028550
  39. 39

    LAPAROSCOPIC ANTIREFLUX SURGERY: ARE OLD QUESTIONS ANSWERED? USEFUL FOR EXTRA-ESOPHAGEAL SYMPTOMS?

    Patti MG, Herbella FAM

    Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery 2022; (34(4)):e1632 doi:10.1590/0102-672020210002e1632.

    PMID: 35107494
  40. 40

    AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.

    Yadlapati R, Gyawali CP, Pandolfino JE,

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(5)):984-994.e1 doi:10.1016/j.cgh.2022.01.025.

    PMID: 35123084
  41. 41

    Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn.

    Frazzoni M, Frazzoni L, Ribolsi M, et al.

    Alimentary pharmacology & therapeutics 2022; (55(11)):1423-1430 doi:10.1111/apt.16838.

    PMID: 35229321
  42. 42

    Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.

    Shaheen NJ, Falk GW, Iyer PG, et al.

    The American journal of gastroenterology 2022; (117(4)):559-587 doi:10.14309/ajg.0000000000001680.

    PMID: 35354777
  43. 43

    Gastroesophageal reflux disease and oral health: A narrative review.

    Mahajan R, Kulkarni R, Stoopler ET

    Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 2022; (42(6)):555-564 doi:10.1111/scd.12726.

    PMID: 35605234
  44. 44

    AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review.

    Muthusamy VR, Wani S, Gyawali CP, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(12)):2696-2706.e1 doi:10.1016/j.cgh.2022.06.003.

    PMID: 35788412
  45. 45

    Barrett Esophagus: A Review.

    Sharma P

    JAMA 2022; (328(7)):663-671 doi:10.1001/jama.2022.13298.

    PMID: 35972481
  46. 46

    Identifying hiatal hernia with impedance planimetry during esophageal distension testing.

    Carlson DA, Kahrilas PJ, Simlote A, et al.

    Neurogastroenterology and motility 2023; (35(2)):e14470 doi:10.1111/nmo.14470.

    PMID: 36168153
  47. 47

    Gastroesophageal Reflux Disease (GERD): Highlighting Diagnosis, Treatment, and Lifestyle Changes.

    Chhabra P, Ingole N

    Cureus 2022; (14(8)):e28563 doi:10.7759/cureus.28563.

    PMID: 36185857
  48. 48

    Role of Non-pharmacological Interventions and Weight Loss in the Management of Gastroesophageal Reflux Disease in Obese Individuals: A Systematic Review.

    Mukhtar M, Alzubaidee MJ, Dwarampudi RS, et al.

    Cureus 2022; (14(8)):e28637 doi:10.7759/cureus.28637.

    PMID: 36196334
  49. 49

    Deprescribing proton pump inhibitors.

    Turner JP, Thompson W, Reeve E, Bell JS

    Australian journal of general practice 2022; (51(11)):845-848 doi:10.31128/AJGP-07-22-6497.

    PMID: 36310001
  50. 50

    Efficacy of laparoscopic Toupet fundoplication compared to endoscopic and surgical procedures for GERD treatment: a randomized trials network meta-analysis.

    Rausa E, Ferrari D, Kelly ME, et al.

    Langenbeck's archives of surgery 2023; (408(1)):52 doi:10.1007/s00423-023-02774-y.

    PMID: 36680602
  51. 51

    Obesity, sleeve gastrectomy and gastro-esophageal reflux disease.

    Veziant J, Benhalima S, Piessen G, Slim K

    Journal of visceral surgery 2023; (160(2S)):S47-S54 doi:10.1016/j.jviscsurg.2023.01.004.

    PMID: 36725450
  52. 52

    Nissen Versus Toupet Fundoplication For Gastro-oesophageal Reflux Disease, Short And Long-term Outcomes. A Systematic Review And Meta-analysis.

    Salman MA, Salman A, Shaaban HE, et al.

    Surgical laparoscopy, endoscopy & percutaneous techniques 2023; (33(2)):171-183 doi:10.1097/SLE.0000000000001139.

    PMID: 36971517
  53. 53

    Gastroesophageal Reflux Disease in 2023: When to Operate and Current Endoscopic Options for Antireflux Therapy.

    Shah A, Kim MP

    Thoracic surgery clinics 2023; (33(2)):125-134 doi:10.1016/j.thorsurg.2023.01.010.

    PMID: 37045481
  54. 54

    Dietary factors involved in GERD management.

    Fox M, Gyawali CP

    Best practice & research. Clinical gastroenterology 2023; (62-63()):101826 doi:10.1016/j.bpg.2023.101826.

    PMID: 37094911
  55. 55

    Should All Patients with Barrett's Esophagus Receive Ablation?

    Shafa S, Carroll JE

    Current gastroenterology reports 2023; (25(6)):115-121 doi:10.1007/s11894-023-00869-6.

    PMID: 37204654
  56. 56

    Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management.

    Argüero J, Sifrim D

    Nature reviews. Gastroenterology & hepatology 2024; (21(4)):282-293 doi:10.1038/s41575-023-00883-z.

    PMID: 38177402
  57. 57

    Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass).

    Biter LU, 't Hart JW, Noordman BJ, et al.

    The Lancet regional health. Europe 2024; (38()):100836 doi:10.1016/j.lanepe.2024.100836.

    PMID: 38313139
  58. 58

    Prolonged acid reflux monitoring using acid exposure time and DeMeester score: two days are not enough.

    Lee ME, Ghosh G, Rooney K, et al.

    Surgical endoscopy 2024; (38(5)):2515-2521 doi:10.1007/s00464-024-10733-x.

    PMID: 38467859
  59. 59

    Behavioral Therapy for Functional Heartburn: Recommendation Statements.

    Guadagnoli L, Yadlapati R, Pandolfino J, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(8)):1709-1718.e3 doi:10.1016/j.cgh.2024.03.004.

    PMID: 38518891
  60. 60

    The Role of High-Resolution Manometry Before and Following Antireflux Surgery: The Padova Consensus.

    Salvador R, Pandolfino JE, Costantini M, et al.

    Annals of surgery 2025; (281(1)):124-135 doi:10.1097/SLA.0000000000006297.

    PMID: 38606560
  61. 61

    Value of endoscopic grading of gastroesophageal flap valve in gastroesophageal reflux disease.

    Wang W, Liu Q, Luo L, et al.

    Surgical endoscopy 2024; (38(9)):4956-4964 doi:10.1007/s00464-024-10839-2.

    PMID: 38977497
  62. 62

    Utility of the Post-Reflux Swallow-Induced Peristaltic Wave Index and Mean Nocturnal Baseline Impedance for the Diagnosis of Gastroesophageal Reflux Disease Phenotypes in Children.

    Pop RS, Pop D, Chiperi LE, et al.

    Children (Basel, Switzerland) 2024; (11(7)) doi:10.3390/children11070773.

    PMID: 39062223
  63. 63

    Mean nocturnal baseline impedance in gastro-esophageal reflux disease diagnosis: Should we strictly follow the Lyon 2 Consensus?

    Voulgaris TA, Karamanolis GP

    World journal of gastroenterology 2024; (30(26)):3253-3256 doi:10.3748/wjg.v30.i26.3253.

    PMID: 39086632
  64. 64

    Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024.

    Visaggi P, Bertin L, Pasta A, et al.

    Expert opinion on pharmacotherapy 2024; (25(15)):2077-2088 doi:10.1080/14656566.2024.2416585.

    PMID: 39392340
  65. 65

    Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus.

    Kao SS, Wu DC, Chuah SK, et al.

    Journal of the Formosan Medical Association = Taiwan yi zhi 2026; (125(6)):636-642 doi:10.1016/j.jfma.2025.03.006.

    PMID: 40069015
  66. 66

    When Manometry and Functional Lumen Imaging Probe Disagree: The Current Limitations of the Chicago Classification Version 4.0 and Probable Extended Indications of Functional Lumen Imaging Probe.

    Jung KW, Pandolfino JE

    Journal of neurogastroenterology and motility 2025; (31(3)):304-312 doi:10.5056/jnm25054.

    PMID: 40254534
  67. 67

    Advances in diagnostic techniques for eosinophilic esophagitis: a systematic review of emerging noninvasive methods.

    Al Abdulqader AK

    European journal of medical research 2025; (30(1)):924 doi:10.1186/s40001-025-02989-3.

    PMID: 41034999
  68. 68

    Association between body mass index at different levels and risk of gastroesophageal reflux disease: a systematic review with dose-response meta-analysis.

    Yiqing M, Yangyang Z, Lanshuo H, et al.

    Frontiers in physiology 2025; (16()):1675457 doi:10.3389/fphys.2025.1675457.

    PMID: 41384250
  69. 69

    Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus.

    Vissapragada R, Bulamu NB, Yazbeck R, et al.

    Journal of gastroenterology and hepatology 2026; (41(3)):992-1000 doi:10.1111/jgh.70238.

    PMID: 41553019
  70. 70

    [Use of Los Angeles Classification in Erosive Esophagitis: analysis of inter-observer and intra-observer agreement].

    de Los Rios AA, Olmos JI, Sanguinetti JM, et al.

    Acta gastroenterologica Latinoamericana 2025; (55(4)):350-357 doi:10.52787/agl.v55i4.559.

    PMID: 41800372
  71. 71

    Early life stress and the pathogenesis of visceral hypersensitivity: mechanisms and implications for disorders of gut-brain interaction.

    Tao E

    Frontiers in cell and developmental biology 2026; (14()):1827148 doi:10.3389/fcell.2026.1827148.

    PMID: 42326011
  72. 72

    [Modern Diagnostic Strategies for Gastroesophageal Reflux Disease: Focus on Lyon Consensus 2.0].

    Lee TH

    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2026; (86(3)):193-198 doi:10.4166/kjg.2026.038.

    PMID: 42494146